Manufacturing News of Note: Catalent expands; Hospira and Novartis issue recalls

stocks
(Pixabay)

> Catalent is investing $9 million in a clinical supply facility in San Diego, California. Release

> Nichi-Iko Pharmaceutical, parent of Sagent Pharmaceuticals, says its Canadian subsidiary, Omega Laboratories, has won FDA approval for its site in Montreal to manufacture products for the U.S. Release

> Pfizer's Hospira is voluntarily recalling one lot of bacteriostatic water used to dilute drugs because vials may not be sterile and bring a risk of bacterial infections. Release

> Novartis is recalling one lot of asthma med Xolair in Canada because the vials may include silicone oil. Release